nodes	percent_of_prediction	percent_of_DWPC	metapath
Isradipine—CACNA1S—seminal vesicle—urinary bladder cancer	0.02	0.0975	CbGeAlD
Isradipine—CACNA1H—prostate gland—urinary bladder cancer	0.015	0.0734	CbGeAlD
Isradipine—CACNB2—prostate gland—urinary bladder cancer	0.0142	0.0693	CbGeAlD
Isradipine—CACNA2D1—prostate gland—urinary bladder cancer	0.0133	0.0651	CbGeAlD
Isradipine—CACNA1H—seminal vesicle—urinary bladder cancer	0.0127	0.0621	CbGeAlD
Isradipine—CACNA1D—prostate gland—urinary bladder cancer	0.0124	0.0606	CbGeAlD
Isradipine—CYP3A4—urine—urinary bladder cancer	0.0118	0.0575	CbGeAlD
Isradipine—CACNA1C—prostate gland—urinary bladder cancer	0.0115	0.0559	CbGeAlD
Isradipine—CACNA1H—smooth muscle tissue—urinary bladder cancer	0.0106	0.052	CbGeAlD
Isradipine—CACNA2D2—vagina—urinary bladder cancer	0.00915	0.0447	CbGeAlD
Isradipine—CACNA1H—female reproductive system—urinary bladder cancer	0.00821	0.0401	CbGeAlD
Isradipine—CACNA1C—smooth muscle tissue—urinary bladder cancer	0.00811	0.0396	CbGeAlD
Isradipine—CACNB2—vagina—urinary bladder cancer	0.00701	0.0342	CbGeAlD
Isradipine—CACNA2D1—vagina—urinary bladder cancer	0.00658	0.0321	CbGeAlD
Isradipine—CACNA1C—female reproductive system—urinary bladder cancer	0.00626	0.0305	CbGeAlD
Isradipine—CACNA2D2—lymph node—urinary bladder cancer	0.00592	0.0289	CbGeAlD
Isradipine—CACNA1C—vagina—urinary bladder cancer	0.00566	0.0276	CbGeAlD
Isradipine—CACNA1H—lymph node—urinary bladder cancer	0.0048	0.0234	CbGeAlD
Isradipine—CACNB2—lymph node—urinary bladder cancer	0.00454	0.0221	CbGeAlD
Isradipine—CACNA2D1—lymph node—urinary bladder cancer	0.00426	0.0208	CbGeAlD
Isradipine—CACNA1D—lymph node—urinary bladder cancer	0.00396	0.0193	CbGeAlD
Isradipine—CACNA1C—lymph node—urinary bladder cancer	0.00366	0.0179	CbGeAlD
Isradipine—CYP3A4—renal system—urinary bladder cancer	0.00288	0.0141	CbGeAlD
Isradipine—CYP3A4—female reproductive system—urinary bladder cancer	0.00231	0.0113	CbGeAlD
Isradipine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000986	0.00153	CcSEcCtD
Isradipine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000985	0.00152	CcSEcCtD
Isradipine—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000981	0.00152	CcSEcCtD
Isradipine—Angina pectoris—Epirubicin—urinary bladder cancer	0.00098	0.00152	CcSEcCtD
Isradipine—Breast disorder—Doxorubicin—urinary bladder cancer	0.000973	0.0015	CcSEcCtD
Isradipine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000972	0.0015	CcSEcCtD
Isradipine—Decreased appetite—Cisplatin—urinary bladder cancer	0.000968	0.0015	CcSEcCtD
Isradipine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000968	0.0015	CcSEcCtD
Isradipine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000962	0.00149	CcSEcCtD
Isradipine—Drowsiness—Methotrexate—urinary bladder cancer	0.000958	0.00148	CcSEcCtD
Isradipine—Depression—Methotrexate—urinary bladder cancer	0.000956	0.00148	CcSEcCtD
Isradipine—Hypotension—Etoposide—urinary bladder cancer	0.000953	0.00147	CcSEcCtD
Isradipine—Dizziness—Thiotepa—urinary bladder cancer	0.000939	0.00145	CcSEcCtD
Isradipine—Urticaria—Fluorouracil—urinary bladder cancer	0.000933	0.00144	CcSEcCtD
Isradipine—Pollakiuria—Epirubicin—urinary bladder cancer	0.000929	0.00144	CcSEcCtD
Isradipine—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000918	0.00142	CcSEcCtD
Isradipine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000918	0.00142	CcSEcCtD
Isradipine—Paraesthesia—Etoposide—urinary bladder cancer	0.000916	0.00142	CcSEcCtD
Isradipine—Weight increased—Epirubicin—urinary bladder cancer	0.000915	0.00142	CcSEcCtD
Isradipine—Dyspnoea—Etoposide—urinary bladder cancer	0.00091	0.00141	CcSEcCtD
Isradipine—Somnolence—Etoposide—urinary bladder cancer	0.000907	0.0014	CcSEcCtD
Isradipine—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000907	0.0014	CcSEcCtD
Isradipine—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000906	0.0014	CcSEcCtD
Isradipine—Vomiting—Thiotepa—urinary bladder cancer	0.000903	0.0014	CcSEcCtD
Isradipine—Drowsiness—Epirubicin—urinary bladder cancer	0.000897	0.00139	CcSEcCtD
Isradipine—Rash—Thiotepa—urinary bladder cancer	0.000896	0.00139	CcSEcCtD
Isradipine—Dermatitis—Thiotepa—urinary bladder cancer	0.000895	0.00138	CcSEcCtD
Isradipine—Headache—Thiotepa—urinary bladder cancer	0.00089	0.00138	CcSEcCtD
Isradipine—Decreased appetite—Etoposide—urinary bladder cancer	0.000887	0.00137	CcSEcCtD
Isradipine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000881	0.00136	CcSEcCtD
Isradipine—Fatigue—Etoposide—urinary bladder cancer	0.00088	0.00136	CcSEcCtD
Isradipine—Constipation—Etoposide—urinary bladder cancer	0.000873	0.00135	CcSEcCtD
Isradipine—Hepatitis—Methotrexate—urinary bladder cancer	0.00086	0.00133	CcSEcCtD
Isradipine—Pollakiuria—Doxorubicin—urinary bladder cancer	0.00086	0.00133	CcSEcCtD
Isradipine—Asthenia—Gemcitabine—urinary bladder cancer	0.000857	0.00133	CcSEcCtD
Isradipine—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.00085	0.00131	CcSEcCtD
Isradipine—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000849	0.00131	CcSEcCtD
Isradipine—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000848	0.00131	CcSEcCtD
Isradipine—Weight increased—Doxorubicin—urinary bladder cancer	0.000847	0.00131	CcSEcCtD
Isradipine—Pruritus—Gemcitabine—urinary bladder cancer	0.000845	0.00131	CcSEcCtD
Isradipine—Nausea—Thiotepa—urinary bladder cancer	0.000844	0.0013	CcSEcCtD
Isradipine—Urethral disorder—Methotrexate—urinary bladder cancer	0.000843	0.0013	CcSEcCtD
Isradipine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000841	0.0013	CcSEcCtD
Isradipine—Pruritus—Fluorouracil—urinary bladder cancer	0.000831	0.00129	CcSEcCtD
Isradipine—Drowsiness—Doxorubicin—urinary bladder cancer	0.00083	0.00128	CcSEcCtD
Isradipine—Visual impairment—Methotrexate—urinary bladder cancer	0.000829	0.00128	CcSEcCtD
Isradipine—Bradycardia—Epirubicin—urinary bladder cancer	0.00082	0.00127	CcSEcCtD
Isradipine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000818	0.00126	CcSEcCtD
Isradipine—Urticaria—Etoposide—urinary bladder cancer	0.000811	0.00125	CcSEcCtD
Isradipine—Hepatitis—Epirubicin—urinary bladder cancer	0.000805	0.00125	CcSEcCtD
Isradipine—Eye disorder—Methotrexate—urinary bladder cancer	0.000804	0.00124	CcSEcCtD
Isradipine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000804	0.00124	CcSEcCtD
Isradipine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000801	0.00124	CcSEcCtD
Isradipine—Asthenia—Cisplatin—urinary bladder cancer	0.000799	0.00124	CcSEcCtD
Isradipine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000798	0.00123	CcSEcCtD
Isradipine—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000795	0.00123	CcSEcCtD
Isradipine—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000793	0.00123	CcSEcCtD
Isradipine—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000791	0.00122	CcSEcCtD
Isradipine—Urethral disorder—Epirubicin—urinary bladder cancer	0.000789	0.00122	CcSEcCtD
Isradipine—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000785	0.00121	CcSEcCtD
Isradipine—Angiopathy—Methotrexate—urinary bladder cancer	0.000781	0.00121	CcSEcCtD
Isradipine—Immune system disorder—Methotrexate—urinary bladder cancer	0.000777	0.0012	CcSEcCtD
Isradipine—Dizziness—Fluorouracil—urinary bladder cancer	0.000777	0.0012	CcSEcCtD
Isradipine—Visual impairment—Epirubicin—urinary bladder cancer	0.000776	0.0012	CcSEcCtD
Isradipine—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000775	0.0012	CcSEcCtD
Isradipine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000762	0.00118	CcSEcCtD
Isradipine—Vomiting—Gemcitabine—urinary bladder cancer	0.00076	0.00118	CcSEcCtD
Isradipine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000758	0.00117	CcSEcCtD
Isradipine—Mental disorder—Methotrexate—urinary bladder cancer	0.000754	0.00117	CcSEcCtD
Isradipine—Rash—Gemcitabine—urinary bladder cancer	0.000753	0.00117	CcSEcCtD
Isradipine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000753	0.00116	CcSEcCtD
Isradipine—Eye disorder—Epirubicin—urinary bladder cancer	0.000752	0.00116	CcSEcCtD
Isradipine—Malnutrition—Methotrexate—urinary bladder cancer	0.000749	0.00116	CcSEcCtD
Isradipine—Headache—Gemcitabine—urinary bladder cancer	0.000749	0.00116	CcSEcCtD
Isradipine—Flushing—Epirubicin—urinary bladder cancer	0.000747	0.00116	CcSEcCtD
Isradipine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000747	0.00116	CcSEcCtD
Isradipine—Vomiting—Fluorouracil—urinary bladder cancer	0.000747	0.00116	CcSEcCtD
Isradipine—Hepatitis—Doxorubicin—urinary bladder cancer	0.000745	0.00115	CcSEcCtD
Isradipine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000741	0.00115	CcSEcCtD
Isradipine—Rash—Fluorouracil—urinary bladder cancer	0.000741	0.00115	CcSEcCtD
Isradipine—Dermatitis—Fluorouracil—urinary bladder cancer	0.00074	0.00114	CcSEcCtD
Isradipine—Headache—Fluorouracil—urinary bladder cancer	0.000736	0.00114	CcSEcCtD
Isradipine—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000736	0.00114	CcSEcCtD
Isradipine—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000734	0.00113	CcSEcCtD
Isradipine—Asthenia—Etoposide—urinary bladder cancer	0.000732	0.00113	CcSEcCtD
Isradipine—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000732	0.00113	CcSEcCtD
Isradipine—Angiopathy—Epirubicin—urinary bladder cancer	0.00073	0.00113	CcSEcCtD
Isradipine—Urethral disorder—Doxorubicin—urinary bladder cancer	0.00073	0.00113	CcSEcCtD
Isradipine—Immune system disorder—Epirubicin—urinary bladder cancer	0.000727	0.00112	CcSEcCtD
Isradipine—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000726	0.00112	CcSEcCtD
Isradipine—Back pain—Methotrexate—urinary bladder cancer	0.000724	0.00112	CcSEcCtD
Isradipine—Pruritus—Etoposide—urinary bladder cancer	0.000722	0.00112	CcSEcCtD
Isradipine—Visual impairment—Doxorubicin—urinary bladder cancer	0.000718	0.00111	CcSEcCtD
Isradipine—Nausea—Gemcitabine—urinary bladder cancer	0.00071	0.0011	CcSEcCtD
Isradipine—Vomiting—Cisplatin—urinary bladder cancer	0.000708	0.0011	CcSEcCtD
Isradipine—Vision blurred—Methotrexate—urinary bladder cancer	0.000706	0.00109	CcSEcCtD
Isradipine—Mental disorder—Epirubicin—urinary bladder cancer	0.000705	0.00109	CcSEcCtD
Isradipine—Rash—Cisplatin—urinary bladder cancer	0.000702	0.00109	CcSEcCtD
Isradipine—Dermatitis—Cisplatin—urinary bladder cancer	0.000702	0.00109	CcSEcCtD
Isradipine—Malnutrition—Epirubicin—urinary bladder cancer	0.000701	0.00108	CcSEcCtD
Isradipine—Diarrhoea—Etoposide—urinary bladder cancer	0.000698	0.00108	CcSEcCtD
Isradipine—Nausea—Fluorouracil—urinary bladder cancer	0.000698	0.00108	CcSEcCtD
Isradipine—Eye disorder—Doxorubicin—urinary bladder cancer	0.000696	0.00108	CcSEcCtD
Isradipine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000695	0.00107	CcSEcCtD
Isradipine—Anaemia—Methotrexate—urinary bladder cancer	0.000692	0.00107	CcSEcCtD
Isradipine—Flushing—Doxorubicin—urinary bladder cancer	0.000691	0.00107	CcSEcCtD
Isradipine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000691	0.00107	CcSEcCtD
Isradipine—Tension—Epirubicin—urinary bladder cancer	0.000688	0.00106	CcSEcCtD
Isradipine—Nervousness—Epirubicin—urinary bladder cancer	0.000681	0.00105	CcSEcCtD
Isradipine—Back pain—Epirubicin—urinary bladder cancer	0.000678	0.00105	CcSEcCtD
Isradipine—Angiopathy—Doxorubicin—urinary bladder cancer	0.000676	0.00105	CcSEcCtD
Isradipine—Malaise—Methotrexate—urinary bladder cancer	0.000675	0.00104	CcSEcCtD
Isradipine—Dizziness—Etoposide—urinary bladder cancer	0.000675	0.00104	CcSEcCtD
Isradipine—Muscle spasms—Epirubicin—urinary bladder cancer	0.000674	0.00104	CcSEcCtD
Isradipine—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000673	0.00104	CcSEcCtD
Isradipine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000671	0.00104	CcSEcCtD
Isradipine—Leukopenia—Methotrexate—urinary bladder cancer	0.00067	0.00104	CcSEcCtD
Isradipine—Nausea—Cisplatin—urinary bladder cancer	0.000662	0.00102	CcSEcCtD
Isradipine—Vision blurred—Epirubicin—urinary bladder cancer	0.00066	0.00102	CcSEcCtD
Isradipine—Cough—Methotrexate—urinary bladder cancer	0.000653	0.00101	CcSEcCtD
Isradipine—Mental disorder—Doxorubicin—urinary bladder cancer	0.000653	0.00101	CcSEcCtD
Isradipine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.00065	0.00101	CcSEcCtD
Isradipine—Vomiting—Etoposide—urinary bladder cancer	0.000649	0.001	CcSEcCtD
Isradipine—Malnutrition—Doxorubicin—urinary bladder cancer	0.000648	0.001	CcSEcCtD
Isradipine—Anaemia—Epirubicin—urinary bladder cancer	0.000648	0.001	CcSEcCtD
Isradipine—Rash—Etoposide—urinary bladder cancer	0.000643	0.000995	CcSEcCtD
Isradipine—Dermatitis—Etoposide—urinary bladder cancer	0.000643	0.000994	CcSEcCtD
Isradipine—Headache—Etoposide—urinary bladder cancer	0.000639	0.000989	CcSEcCtD
Isradipine—Arthralgia—Methotrexate—urinary bladder cancer	0.000638	0.000986	CcSEcCtD
Isradipine—Chest pain—Methotrexate—urinary bladder cancer	0.000638	0.000986	CcSEcCtD
Isradipine—Tension—Doxorubicin—urinary bladder cancer	0.000636	0.000984	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000633	0.000979	CcSEcCtD
Isradipine—Malaise—Epirubicin—urinary bladder cancer	0.000632	0.000977	CcSEcCtD
Isradipine—Discomfort—Methotrexate—urinary bladder cancer	0.00063	0.000974	CcSEcCtD
Isradipine—Nervousness—Doxorubicin—urinary bladder cancer	0.00063	0.000974	CcSEcCtD
Isradipine—Syncope—Epirubicin—urinary bladder cancer	0.000628	0.000972	CcSEcCtD
Isradipine—Leukopenia—Epirubicin—urinary bladder cancer	0.000627	0.00097	CcSEcCtD
Isradipine—Back pain—Doxorubicin—urinary bladder cancer	0.000627	0.00097	CcSEcCtD
Isradipine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000623	0.000964	CcSEcCtD
Isradipine—Palpitations—Epirubicin—urinary bladder cancer	0.000619	0.000958	CcSEcCtD
Isradipine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000616	0.000953	CcSEcCtD
Isradipine—Cough—Epirubicin—urinary bladder cancer	0.000612	0.000946	CcSEcCtD
Isradipine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000611	0.000945	CcSEcCtD
Isradipine—Vision blurred—Doxorubicin—urinary bladder cancer	0.000611	0.000945	CcSEcCtD
Isradipine—Nausea—Etoposide—urinary bladder cancer	0.000606	0.000937	CcSEcCtD
Isradipine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000602	0.000931	CcSEcCtD
Isradipine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000599	0.000927	CcSEcCtD
Isradipine—Anaemia—Doxorubicin—urinary bladder cancer	0.000599	0.000927	CcSEcCtD
Isradipine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000598	0.000925	CcSEcCtD
Isradipine—Arthralgia—Epirubicin—urinary bladder cancer	0.000597	0.000923	CcSEcCtD
Isradipine—Chest pain—Epirubicin—urinary bladder cancer	0.000597	0.000923	CcSEcCtD
Isradipine—Anxiety—Epirubicin—urinary bladder cancer	0.000595	0.00092	CcSEcCtD
Isradipine—Skin disorder—Methotrexate—urinary bladder cancer	0.000594	0.000918	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000593	0.000916	CcSEcCtD
Isradipine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000591	0.000914	CcSEcCtD
Isradipine—Discomfort—Epirubicin—urinary bladder cancer	0.00059	0.000912	CcSEcCtD
Isradipine—Malaise—Doxorubicin—urinary bladder cancer	0.000585	0.000904	CcSEcCtD
Isradipine—Dry mouth—Epirubicin—urinary bladder cancer	0.000584	0.000902	CcSEcCtD
Isradipine—Syncope—Doxorubicin—urinary bladder cancer	0.000582	0.000899	CcSEcCtD
Isradipine—Leukopenia—Doxorubicin—urinary bladder cancer	0.00058	0.000898	CcSEcCtD
Isradipine—Palpitations—Doxorubicin—urinary bladder cancer	0.000573	0.000886	CcSEcCtD
Isradipine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000572	0.000885	CcSEcCtD
Isradipine—Oedema—Epirubicin—urinary bladder cancer	0.000572	0.000885	CcSEcCtD
Isradipine—Hypotension—Methotrexate—urinary bladder cancer	0.000571	0.000883	CcSEcCtD
Isradipine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.00057	0.000881	CcSEcCtD
Isradipine—Cough—Doxorubicin—urinary bladder cancer	0.000566	0.000875	CcSEcCtD
Isradipine—Shock—Epirubicin—urinary bladder cancer	0.000563	0.00087	CcSEcCtD
Isradipine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000561	0.000867	CcSEcCtD
Isradipine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.00056	0.000866	CcSEcCtD
Isradipine—Tachycardia—Epirubicin—urinary bladder cancer	0.000558	0.000863	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000557	0.000861	CcSEcCtD
Isradipine—Skin disorder—Epirubicin—urinary bladder cancer	0.000556	0.000859	CcSEcCtD
Isradipine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000553	0.000855	CcSEcCtD
Isradipine—Insomnia—Methotrexate—urinary bladder cancer	0.000553	0.000855	CcSEcCtD
Isradipine—Chest pain—Doxorubicin—urinary bladder cancer	0.000552	0.000854	CcSEcCtD
Isradipine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000552	0.000854	CcSEcCtD
Isradipine—Anxiety—Doxorubicin—urinary bladder cancer	0.00055	0.000851	CcSEcCtD
Isradipine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000549	0.000849	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000548	0.000848	CcSEcCtD
Isradipine—Discomfort—Doxorubicin—urinary bladder cancer	0.000545	0.000844	CcSEcCtD
Isradipine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000545	0.000843	CcSEcCtD
Isradipine—Somnolence—Methotrexate—urinary bladder cancer	0.000543	0.00084	CcSEcCtD
Isradipine—Dry mouth—Doxorubicin—urinary bladder cancer	0.00054	0.000835	CcSEcCtD
Isradipine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000538	0.000832	CcSEcCtD
Isradipine—Hypotension—Epirubicin—urinary bladder cancer	0.000534	0.000827	CcSEcCtD
Isradipine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000531	0.000822	CcSEcCtD
Isradipine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000529	0.000818	CcSEcCtD
Isradipine—Oedema—Doxorubicin—urinary bladder cancer	0.000529	0.000818	CcSEcCtD
Isradipine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000528	0.000816	CcSEcCtD
Isradipine—Fatigue—Methotrexate—urinary bladder cancer	0.000527	0.000815	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000521	0.000806	CcSEcCtD
Isradipine—Shock—Doxorubicin—urinary bladder cancer	0.000521	0.000805	CcSEcCtD
Isradipine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000519	0.000803	CcSEcCtD
Isradipine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000518	0.000801	CcSEcCtD
Isradipine—Insomnia—Epirubicin—urinary bladder cancer	0.000517	0.0008	CcSEcCtD
Isradipine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000517	0.000799	CcSEcCtD
Isradipine—Skin disorder—Doxorubicin—urinary bladder cancer	0.000514	0.000795	CcSEcCtD
Isradipine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000514	0.000794	CcSEcCtD
Isradipine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000512	0.000791	CcSEcCtD
Isradipine—Dyspnoea—Epirubicin—urinary bladder cancer	0.00051	0.000789	CcSEcCtD
Isradipine—Somnolence—Epirubicin—urinary bladder cancer	0.000508	0.000786	CcSEcCtD
Isradipine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000504	0.000779	CcSEcCtD
Isradipine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000503	0.000779	CcSEcCtD
Isradipine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000497	0.000769	CcSEcCtD
Isradipine—Hypotension—Doxorubicin—urinary bladder cancer	0.000495	0.000765	CcSEcCtD
Isradipine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000494	0.000764	CcSEcCtD
Isradipine—Fatigue—Epirubicin—urinary bladder cancer	0.000493	0.000763	CcSEcCtD
Isradipine—Constipation—Epirubicin—urinary bladder cancer	0.000489	0.000756	CcSEcCtD
Isradipine—Urticaria—Methotrexate—urinary bladder cancer	0.000486	0.000751	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000482	0.000746	CcSEcCtD
Isradipine—Insomnia—Doxorubicin—urinary bladder cancer	0.000479	0.00074	CcSEcCtD
Isradipine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000475	0.000735	CcSEcCtD
Isradipine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000472	0.00073	CcSEcCtD
Isradipine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000471	0.000729	CcSEcCtD
Isradipine—Somnolence—Doxorubicin—urinary bladder cancer	0.00047	0.000728	CcSEcCtD
Isradipine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000466	0.00072	CcSEcCtD
Isradipine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.00046	0.000712	CcSEcCtD
Isradipine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000457	0.000707	CcSEcCtD
Isradipine—Fatigue—Doxorubicin—urinary bladder cancer	0.000456	0.000706	CcSEcCtD
Isradipine—Urticaria—Epirubicin—urinary bladder cancer	0.000454	0.000703	CcSEcCtD
Isradipine—CACNB2—Metabolism—GSTZ1—urinary bladder cancer	0.000454	0.00306	CbGpPWpGaD
Isradipine—Constipation—Doxorubicin—urinary bladder cancer	0.000453	0.0007	CcSEcCtD
Isradipine—CACNA1C—NCAM signaling for neurite out-growth—KRAS—urinary bladder cancer	0.00045	0.00303	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000448	0.00302	CbGpPWpGaD
Isradipine—Asthenia—Methotrexate—urinary bladder cancer	0.000439	0.000678	CcSEcCtD
Isradipine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000436	0.000674	CcSEcCtD
Isradipine—CACNA1D—NCAM signaling for neurite out-growth—HRAS—urinary bladder cancer	0.000435	0.00293	CbGpPWpGaD
Isradipine—Pruritus—Methotrexate—urinary bladder cancer	0.000432	0.000669	CcSEcCtD
Isradipine—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.000431	0.0029	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.000431	0.0029	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—NAT1—urinary bladder cancer	0.00043	0.0029	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GSTO2—urinary bladder cancer	0.00043	0.0029	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GSTZ1—urinary bladder cancer	0.00043	0.0029	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000425	0.00286	CbGpPWpGaD
Isradipine—Urticaria—Doxorubicin—urinary bladder cancer	0.00042	0.00065	CcSEcCtD
Isradipine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000418	0.000647	CcSEcCtD
Isradipine—Asthenia—Epirubicin—urinary bladder cancer	0.00041	0.000635	CcSEcCtD
Isradipine—CACNA1D—Metabolism—GSTO2—urinary bladder cancer	0.000408	0.00275	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—NAT1—urinary bladder cancer	0.000408	0.00275	CbGpPWpGaD
Isradipine—Pruritus—Epirubicin—urinary bladder cancer	0.000405	0.000626	CcSEcCtD
Isradipine—Dizziness—Methotrexate—urinary bladder cancer	0.000404	0.000625	CcSEcCtD
Isradipine—CACNA1D—Alzheimers Disease—TP53—urinary bladder cancer	0.000403	0.00272	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—NCOR1—urinary bladder cancer	0.000403	0.00271	CbGpPWpGaD
Isradipine—CACNA1C—Alzheimers Disease—TNF—urinary bladder cancer	0.000402	0.00271	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000394	0.00265	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—UGT2B7—urinary bladder cancer	0.000394	0.00265	CbGpPWpGaD
Isradipine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000391	0.000605	CcSEcCtD
Isradipine—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000389	0.00262	CbGpPWpGaD
Isradipine—Vomiting—Methotrexate—urinary bladder cancer	0.000389	0.000601	CcSEcCtD
Isradipine—Rash—Methotrexate—urinary bladder cancer	0.000385	0.000596	CcSEcCtD
Isradipine—Dermatitis—Methotrexate—urinary bladder cancer	0.000385	0.000595	CcSEcCtD
Isradipine—Headache—Methotrexate—urinary bladder cancer	0.000383	0.000592	CcSEcCtD
Isradipine—CACNA1C—NCAM signaling for neurite out-growth—HRAS—urinary bladder cancer	0.000382	0.00257	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—TYMP—urinary bladder cancer	0.00038	0.00256	CbGpPWpGaD
Isradipine—Asthenia—Doxorubicin—urinary bladder cancer	0.00038	0.000587	CcSEcCtD
Isradipine—Dizziness—Epirubicin—urinary bladder cancer	0.000378	0.000585	CcSEcCtD
Isradipine—CACNA1C—Metabolism—GSTZ1—urinary bladder cancer	0.000378	0.00254	CbGpPWpGaD
Isradipine—Pruritus—Doxorubicin—urinary bladder cancer	0.000374	0.000579	CcSEcCtD
Isradipine—CACNA1D—Metabolism—UGT2B7—urinary bladder cancer	0.000373	0.00251	CbGpPWpGaD
Isradipine—Vomiting—Epirubicin—urinary bladder cancer	0.000364	0.000562	CcSEcCtD
Isradipine—Nausea—Methotrexate—urinary bladder cancer	0.000363	0.000561	CcSEcCtD
Isradipine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000362	0.00056	CcSEcCtD
Isradipine—Rash—Epirubicin—urinary bladder cancer	0.000361	0.000558	CcSEcCtD
Isradipine—Dermatitis—Epirubicin—urinary bladder cancer	0.00036	0.000557	CcSEcCtD
Isradipine—Headache—Epirubicin—urinary bladder cancer	0.000358	0.000554	CcSEcCtD
Isradipine—CACNA1C—Metabolism—GSTO2—urinary bladder cancer	0.000358	0.00241	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—NAT1—urinary bladder cancer	0.000358	0.00241	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000355	0.00239	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CYP4B1—urinary bladder cancer	0.000354	0.00239	CbGpPWpGaD
Isradipine—CACNA1C—Alzheimers Disease—TP53—urinary bladder cancer	0.000354	0.00239	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—RHOA—urinary bladder cancer	0.000351	0.00237	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00035	0.00236	CbGpPWpGaD
Isradipine—Dizziness—Doxorubicin—urinary bladder cancer	0.00035	0.000541	CcSEcCtD
Isradipine—CACNA2D2—Metabolism—NAT2—urinary bladder cancer	0.000344	0.00232	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—NCOR1—urinary bladder cancer	0.000342	0.0023	CbGpPWpGaD
Isradipine—Nausea—Epirubicin—urinary bladder cancer	0.00034	0.000525	CcSEcCtD
Isradipine—Vomiting—Doxorubicin—urinary bladder cancer	0.000336	0.00052	CcSEcCtD
Isradipine—CACNA1D—Metabolism—CYP4B1—urinary bladder cancer	0.000336	0.00226	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—SLC19A1—urinary bladder cancer	0.000335	0.00225	CbGpPWpGaD
Isradipine—Rash—Doxorubicin—urinary bladder cancer	0.000334	0.000516	CcSEcCtD
Isradipine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000333	0.000516	CcSEcCtD
Isradipine—Headache—Doxorubicin—urinary bladder cancer	0.000332	0.000513	CcSEcCtD
Isradipine—CACNA1C—Metabolism—UGT2B7—urinary bladder cancer	0.000328	0.00221	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PRSS3—urinary bladder cancer	0.000326	0.0022	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—ERBB2—urinary bladder cancer	0.000325	0.00219	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—CDK4—urinary bladder cancer	0.000318	0.00214	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—SLC19A1—urinary bladder cancer	0.000317	0.00213	CbGpPWpGaD
Isradipine—Nausea—Doxorubicin—urinary bladder cancer	0.000314	0.000486	CcSEcCtD
Isradipine—CACNA1D—Metabolism—PRSS3—urinary bladder cancer	0.000309	0.00208	CbGpPWpGaD
Isradipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000306	0.00206	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—RHOA—urinary bladder cancer	0.000298	0.00201	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—RRM2—urinary bladder cancer	0.000297	0.002	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CYP4B1—urinary bladder cancer	0.000295	0.00199	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—NCOR1—urinary bladder cancer	0.000293	0.00197	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—PPARG—urinary bladder cancer	0.000288	0.00194	CbGpPWpGaD
Isradipine—CACNA2D2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000283	0.0019	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—MMP9—urinary bladder cancer	0.000279	0.00188	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—SLC19A1—urinary bladder cancer	0.000279	0.00188	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—NCOR1—urinary bladder cancer	0.000277	0.00187	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—CREBBP—urinary bladder cancer	0.000277	0.00187	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—ERBB2—urinary bladder cancer	0.000276	0.00186	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—HPGDS—urinary bladder cancer	0.000275	0.00185	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—ENO2—urinary bladder cancer	0.000275	0.00185	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PRSS3—urinary bladder cancer	0.000271	0.00183	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—CDK4—urinary bladder cancer	0.000269	0.00181	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—GSTT1—urinary bladder cancer	0.000267	0.0018	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—TYMP—urinary bladder cancer	0.000261	0.00176	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—SRC—urinary bladder cancer	0.000257	0.00173	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—RHOA—urinary bladder cancer	0.000256	0.00172	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—RHOA—urinary bladder cancer	0.000251	0.00169	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—TYMP—urinary bladder cancer	0.000247	0.00166	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—PPARG—urinary bladder cancer	0.000245	0.00165	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—NCOR1—urinary bladder cancer	0.000244	0.00164	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—RHOA—urinary bladder cancer	0.000242	0.00163	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—MMP9—urinary bladder cancer	0.000237	0.00159	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—ERBB2—urinary bladder cancer	0.000237	0.00159	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000236	0.00159	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—NAT2—urinary bladder cancer	0.000236	0.00159	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—CREBBP—urinary bladder cancer	0.000235	0.00158	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000233	0.00157	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—ERBB2—urinary bladder cancer	0.000232	0.00156	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—CDK4—urinary bladder cancer	0.000231	0.00156	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—EGFR—urinary bladder cancer	0.000225	0.00152	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—ERBB2—urinary bladder cancer	0.000224	0.00151	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—NAT2—urinary bladder cancer	0.000223	0.0015	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—NQO1—urinary bladder cancer	0.000222	0.00149	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—CDK4—urinary bladder cancer	0.000219	0.00147	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—SRC—urinary bladder cancer	0.000218	0.00147	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—TYMP—urinary bladder cancer	0.000217	0.00146	CbGpPWpGaD
Isradipine—CACNA2D2—Neuronal System—HRAS—urinary bladder cancer	0.000217	0.00146	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—KRAS—urinary bladder cancer	0.000213	0.00143	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—RHOA—urinary bladder cancer	0.000213	0.00143	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—RHOA—urinary bladder cancer	0.000213	0.00143	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—PPARG—urinary bladder cancer	0.00021	0.00141	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—RRM2—urinary bladder cancer	0.000204	0.00137	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—MMP9—urinary bladder cancer	0.000203	0.00137	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—CREBBP—urinary bladder cancer	0.000202	0.00136	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—MMP9—urinary bladder cancer	0.000199	0.00134	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—PPARG—urinary bladder cancer	0.000199	0.00134	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—ERBB2—urinary bladder cancer	0.000197	0.00133	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—ERBB2—urinary bladder cancer	0.000197	0.00133	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—NAT2—urinary bladder cancer	0.000196	0.00132	CbGpPWpGaD
Isradipine—CACNB2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000194	0.0013	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—RRM2—urinary bladder cancer	0.000193	0.0013	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—CDK4—urinary bladder cancer	0.000192	0.00129	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—MMP9—urinary bladder cancer	0.000192	0.00129	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—EGFR—urinary bladder cancer	0.000191	0.00129	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—CREBBP—urinary bladder cancer	0.000191	0.00129	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000189	0.00127	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—EP300—urinary bladder cancer	0.000189	0.00127	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—HPGDS—urinary bladder cancer	0.000189	0.00127	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ENO2—urinary bladder cancer	0.000189	0.00127	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—SRC—urinary bladder cancer	0.000187	0.00126	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—GSTP1—urinary bladder cancer	0.000185	0.00125	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—SRC—urinary bladder cancer	0.000184	0.00124	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000183	0.00123	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GSTT1—urinary bladder cancer	0.000183	0.00123	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—RHOA—urinary bladder cancer	0.000182	0.00123	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—HRAS—urinary bladder cancer	0.000181	0.00122	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—KRAS—urinary bladder cancer	0.000181	0.00122	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—HPGDS—urinary bladder cancer	0.000179	0.0012	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ENO2—urinary bladder cancer	0.000179	0.0012	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—SRC—urinary bladder cancer	0.000177	0.00119	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—PPARG—urinary bladder cancer	0.000175	0.00118	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GSTT1—urinary bladder cancer	0.000173	0.00117	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—RHOA—urinary bladder cancer	0.000173	0.00116	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—TYMS—urinary bladder cancer	0.000172	0.00116	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—GSTM1—urinary bladder cancer	0.00017	0.00114	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—NCOR1—urinary bladder cancer	0.00017	0.00114	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—RRM2—urinary bladder cancer	0.000169	0.00114	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—MMP9—urinary bladder cancer	0.000169	0.00114	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—MMP9—urinary bladder cancer	0.000169	0.00114	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—ERBB2—urinary bladder cancer	0.000169	0.00114	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—CREBBP—urinary bladder cancer	0.000168	0.00113	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—EGFR—urinary bladder cancer	0.000164	0.0011	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—GPX1—urinary bladder cancer	0.000163	0.0011	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—EGFR—urinary bladder cancer	0.000161	0.00108	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—EP300—urinary bladder cancer	0.00016	0.00108	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—ERBB2—urinary bladder cancer	0.00016	0.00108	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—ERCC2—urinary bladder cancer	0.00016	0.00108	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ENO2—urinary bladder cancer	0.000157	0.00106	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—HPGDS—urinary bladder cancer	0.000157	0.00106	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—SRC—urinary bladder cancer	0.000156	0.00105	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—SRC—urinary bladder cancer	0.000156	0.00105	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—EGFR—urinary bladder cancer	0.000155	0.00105	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—KRAS—urinary bladder cancer	0.000155	0.00104	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—HRAS—urinary bladder cancer	0.000154	0.00103	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—TNF—urinary bladder cancer	0.000153	0.00103	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GSTT1—urinary bladder cancer	0.000152	0.00102	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—KRAS—urinary bladder cancer	0.000152	0.00102	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—NQO1—urinary bladder cancer	0.000152	0.00102	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—RHOA—urinary bladder cancer	0.000152	0.00102	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—MTHFR—urinary bladder cancer	0.00015	0.00101	CbGpPWpGaD
Isradipine—CACNB2—Neuronal System—HRAS—urinary bladder cancer	0.000148	0.001	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—KRAS—urinary bladder cancer	0.000147	0.000988	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—MMP9—urinary bladder cancer	0.000145	0.000975	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—NQO1—urinary bladder cancer	0.000144	0.000969	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—ERBB2—urinary bladder cancer	0.00014	0.000946	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—EP300—urinary bladder cancer	0.000137	0.000925	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—MMP9—urinary bladder cancer	0.000137	0.000924	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—EGFR—urinary bladder cancer	0.000137	0.000919	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—EGFR—urinary bladder cancer	0.000136	0.000919	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—SRC—urinary bladder cancer	0.000134	0.000899	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—HRAS—urinary bladder cancer	0.000132	0.000887	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—EP300—urinary bladder cancer	0.00013	0.000876	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—TNF—urinary bladder cancer	0.00013	0.000876	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—HRAS—urinary bladder cancer	0.000129	0.00087	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—KRAS—urinary bladder cancer	0.000129	0.000868	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—KRAS—urinary bladder cancer	0.000129	0.000868	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000127	0.000855	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GSTP1—urinary bladder cancer	0.000127	0.000854	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—NQO1—urinary bladder cancer	0.000126	0.000852	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—SRC—urinary bladder cancer	0.000126	0.000852	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000125	0.000843	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—HRAS—urinary bladder cancer	0.000125	0.00084	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PPARG—urinary bladder cancer	0.000122	0.00082	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MMP9—urinary bladder cancer	0.000121	0.000812	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GSTP1—urinary bladder cancer	0.00012	0.000808	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—TYMS—urinary bladder cancer	0.000118	0.000794	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—EGFR—urinary bladder cancer	0.000117	0.000788	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—CREBBP—urinary bladder cancer	0.000117	0.000788	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	0.000117	0.000785	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GSTM1—urinary bladder cancer	0.000116	0.000784	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—NCOR1—urinary bladder cancer	0.000116	0.000784	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000115	0.000775	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—EP300—urinary bladder cancer	0.000114	0.000769	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—TYMS—urinary bladder cancer	0.000112	0.000752	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GPX1—urinary bladder cancer	0.000112	0.000751	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—TNF—urinary bladder cancer	0.000111	0.000751	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—SRC—urinary bladder cancer	0.000111	0.000748	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—EGFR—urinary bladder cancer	0.000111	0.000746	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—KRAS—urinary bladder cancer	0.000111	0.000745	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—NCOR1—urinary bladder cancer	0.00011	0.000743	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GSTM1—urinary bladder cancer	0.00011	0.000743	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—HRAS—urinary bladder cancer	0.00011	0.000738	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—HRAS—urinary bladder cancer	0.00011	0.000738	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ERCC2—urinary bladder cancer	0.00011	0.000738	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GPX1—urinary bladder cancer	0.000106	0.000711	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—TNF—urinary bladder cancer	0.000106	0.000711	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GSTP1—urinary bladder cancer	0.000105	0.00071	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—KRAS—urinary bladder cancer	0.000105	0.000705	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ERCC2—urinary bladder cancer	0.000104	0.000698	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—MTHFR—urinary bladder cancer	0.000103	0.000693	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—TYMS—urinary bladder cancer	9.8e-05	0.00066	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—MTHFR—urinary bladder cancer	9.75e-05	0.000657	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—EGFR—urinary bladder cancer	9.74e-05	0.000656	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—NCOR1—urinary bladder cancer	9.69e-05	0.000653	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GSTM1—urinary bladder cancer	9.69e-05	0.000653	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PTGS2—urinary bladder cancer	9.58e-05	0.000645	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—HRAS—urinary bladder cancer	9.4e-05	0.000633	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GPX1—urinary bladder cancer	9.28e-05	0.000625	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—TNF—urinary bladder cancer	9.27e-05	0.000625	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—KRAS—urinary bladder cancer	9.2e-05	0.00062	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ERCC2—urinary bladder cancer	9.11e-05	0.000614	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—HRAS—urinary bladder cancer	8.9e-05	0.000599	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—MTHFR—urinary bladder cancer	8.57e-05	0.000577	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PTEN—urinary bladder cancer	8.36e-05	0.000563	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PPARG—urinary bladder cancer	8.35e-05	0.000562	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CREBBP—urinary bladder cancer	8.02e-05	0.00054	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—EP300—urinary bladder cancer	7.97e-05	0.000537	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PPARG—urinary bladder cancer	7.9e-05	0.000532	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—HRAS—urinary bladder cancer	7.82e-05	0.000527	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	7.77e-05	0.000524	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CREBBP—urinary bladder cancer	7.59e-05	0.000511	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	7.37e-05	0.000496	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	7.37e-05	0.000496	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PPARG—urinary bladder cancer	6.95e-05	0.000468	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	6.74e-05	0.000454	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CREBBP—urinary bladder cancer	6.67e-05	0.000449	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PTGS2—urinary bladder cancer	6.57e-05	0.000442	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PTGS2—urinary bladder cancer	6.22e-05	0.000419	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	6.07e-05	0.000409	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	5.73e-05	0.000386	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PTEN—urinary bladder cancer	5.73e-05	0.000386	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	5.59e-05	0.000376	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PTGS2—urinary bladder cancer	5.46e-05	0.000368	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—EP300—urinary bladder cancer	5.46e-05	0.000368	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PTEN—urinary bladder cancer	5.42e-05	0.000365	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—EP300—urinary bladder cancer	5.17e-05	0.000348	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PTEN—urinary bladder cancer	4.77e-05	0.000321	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—EP300—urinary bladder cancer	4.54e-05	0.000306	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	4.47e-05	0.000301	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	4.04e-05	0.000272	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	3.49e-05	0.000235	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	3.23e-05	0.000217	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	3.23e-05	0.000217	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	3.13e-05	0.000211	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.6e-05	0.000175	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	2.17e-05	0.000146	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	2.02e-05	0.000136	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.99e-05	0.000134	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.99e-05	0.000134	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.91e-05	0.000129	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.88e-05	0.000126	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.76e-05	0.000119	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.43e-05	9.63e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.37e-05	9.25e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.12e-05	7.57e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	9.81e-06	6.6e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—EP300—urinary bladder cancer	9.35e-06	6.3e-05	CbGpPWpGaD
